United Imaging Intelligence: 31 Medical AI Applications Receive CE Marking
Comunicato Precedente
Comunicato Successivo
In addition to this year's certifications, earlier CE approvals already spanned key clinical domains including neurology, cardiology, thoracic care, oncology, and nuclear medicine. Together, these solutions cover the entire clinical workflow from early detection and diagnosis to medical research, while spanning a broad spectrum of imaging modalities. This breadth and depth highlight UII's ability to deliver real-world value across diverse clinical settings.
In Europe, UII's medical AI solutions have already been adopted in five countries, including Spain, Italy, Bosnia and Herzegovina, Poland, and Turkey. The recent CE certifications will further expand UII's partnerships across the European market. Leveraging its comprehensive AI portfolio, UII can bring trusted technologies to more healthcare providers, enabling them to deliver safer, faster, and higher-quality care.
Beyond CE, UII has also achieved 15 clearances from the U.S. FDA and 15 Class III approvals from China's NMPA. Meeting the world's most rigorous regulatory standards demonstrates UII's global readiness and paves the way for broader adoption of medical AI worldwide.
UII believes that by continuously advancing medical AI innovations, we can transform how healthcare is delivered: optimize care pathways, enhance clinical decision-making, and make quality services more accessible to patients around the world.
Photo - https://mma.prnewswire.com/media/2771028/United_Imaging_Intelligence_s_newly_achieved_CE_Certificate__Source_T_V_S_D.jpg
Photo - https://mma.prnewswire.com/media/2771029/Four_Modalities_Covered_UII_s_CE_Certified_Products.jpg
View original content:https://www.prnewswire.co.uk/news-releases/united-imaging-intelligence-31-medical-ai-applications-receive-ce-marking-302553783.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




